Align Technology is a medical instruments & supplies business based in the US. Align Technology shares (ALGN) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $177.23 – an increase of 3.4% over the previous week. Align Technology employs 20,945 staff and has a trailing 12-month revenue of around $4 billion.
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $177.23 |
|---|---|
| 52-week range | $141.74 - $327.49 |
| 50-day moving average | $175.98 |
| 200-day moving average | $215.11 |
| Wall St. target price | $235.70 |
| PE ratio | 30.5 |
| Dividend yield | N/A |
| Earnings per share (TTM) | $5.62 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $173.87 from 2025-04-22
| 1 week (2025-04-17) | 1.44% |
|---|---|
| 1 month (2025-03-24) | 2.05% |
| 3 months (2025-01-24) | -25.47% |
| 6 months (2024-10-24) | -19.66% |
| 1 year (2024-04-24) | -44.59% |
|---|---|
| 2 years (2023-04-24) | -52.11% |
| 3 years (2022-04-22) | 360.57 |
| 5 years (2020-04-24) | 191.97 |
Valuing Align Technology stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Align Technology's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Align Technology's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 31x. In other words, Align Technology shares trade at around 31x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Align Technology's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.0243. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Align Technology's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Align Technology's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $820.6 million.
The EBITDA is a measure of a Align Technology's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $4 billion |
|---|---|
| Operating margin TTM | 18.18% |
| Gross profit TTM | $2.8 billion |
| Return on assets TTM | 6.87% |
| Return on equity TTM | 11.26% |
| Profit margin | 10.54% |
| Book value | $52.16 |
| Market Capitalization | $12.5 billion |
TTM: trailing 12 months
We're not expecting Align Technology to pay a dividend over the next 12 months.
Over the last 12 months, Align Technology's shares have ranged in value from as little as $141.74 up to $327.49. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Align Technology's is 1.73. This would suggest that Align Technology's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Align Technology, Inc. designs, manufactures, and markets Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally. The Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package to treat adults and teens from mild to severe malocclusion and features, and orthodontic needs of teenage or younger patients; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years with a mixture of primary/baby and permanent teeth. This segment also provides Invisalign express, Invisalign lite, and Invisalign moderate; as well as Invisalign Go, Invisalign Go express, and Invisalign Go Plus; retention products, Invisalign training, adjusting tools used by dental professionals during treatment, ancillary Invisalign accessory products, and other oral health products; Invisalign Professional Whitening system; Invisalign Palatal Expander, a 3D printed orthodontic device; and 3D printing solutions. The Imaging Systems and CAD/CAM Services segment offers iTero intraoral scanning system, a single hardware platform for restorative or orthodontic procedures; exocad, a computer-aided design and computer-aided manufacturing (CAD/CAM) software; orthodontist software for digital records storage, orthodontic diagnosis, and fabrication of printed models and retainers; and restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons. This segment also provides Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; Align Oral Health Suite, a digital interface for dental consultations; iTero TimeLapse technology for doctors or practitioners to compare a patient's historic 3D scans to the present-day scan; and subscription software, disposables, rents scanners, and pay per scan services. The company was incorporated in 1997 .
Track the progress of the S&P 500 stocks to make more informed investment decisions.
These are the stocks to buy when you don’t have much to spend.
These are the best day trading apps, according to Finder’s comprehensive analysis.
Explore the best bonuses for opening a new brokerage account.
Stock lending allows investors to loan out their existing stocks, although it has both advantages and disadvantages.
Want to buy and sell international stocks? Here are the top brokers to help you trade global markets.
These are the best discount brokers of 2025 according to Finder’s comprehensive review.
Compare the 7 best stock picking services, according to Finder’s analysis, and learn how to choose the best option for your needs.
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
Webull is a broker with zero-commission trading and a suite of tools to help you invest.